Board has gone strangely silent. Anyone care to e
Post# of 5066
Posted On: 09/10/2014 12:20:44 PM
Board has gone strangely silent. Anyone care to enlighten me on how today's RGBP PR fits into the perfect storm that was supposed to take place this month?
The cynical side of me tells me that Koos and Ichim knew this back in May when they released the "clarification" PR and the volume selling was so friends good release as many of their BMSN and then un-announced RGBP shares before today's PR was released, all under the anticipation of great news being around the corner and hopes of initial $3.00-$5.00 or more pricing of RGBP.
Back in Dec 2013, we were told via PR that BMSN was organizing safety tests plus toxicology tests for dCellVax that were to take 5 months. Now we are in a position of not knowing whether or not these were done in a GLP clinic or not.
So, if not dCellVax just got automatically postponed another 5-6 months it appears, but if dCellVax tests were performed in a GLP clinic, then Koos could release today's Hema PR, tank the price and let friends buy in and then announce later this week the IND of dCellVax in order to make a quick buck.
The non clarity and lack of important information as a pattern in all of Koos' PRs now means you can't trust much of what he says and often what is not said is more important down the line than what is said.
With various people on this board that have connections with the company, today's news and PR does not fit with what has been projected via this board.
Anyone care to clear things up?
The cynical side of me tells me that Koos and Ichim knew this back in May when they released the "clarification" PR and the volume selling was so friends good release as many of their BMSN and then un-announced RGBP shares before today's PR was released, all under the anticipation of great news being around the corner and hopes of initial $3.00-$5.00 or more pricing of RGBP.
Back in Dec 2013, we were told via PR that BMSN was organizing safety tests plus toxicology tests for dCellVax that were to take 5 months. Now we are in a position of not knowing whether or not these were done in a GLP clinic or not.
So, if not dCellVax just got automatically postponed another 5-6 months it appears, but if dCellVax tests were performed in a GLP clinic, then Koos could release today's Hema PR, tank the price and let friends buy in and then announce later this week the IND of dCellVax in order to make a quick buck.
The non clarity and lack of important information as a pattern in all of Koos' PRs now means you can't trust much of what he says and often what is not said is more important down the line than what is said.
With various people on this board that have connections with the company, today's news and PR does not fit with what has been projected via this board.
Anyone care to clear things up?
(0)
(0)RIVULET MEDIA INC. (RIVU) Stock Research Links
Scroll down for more posts ▼